Citigroup’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Citigroup’s Portfolio GBIM Stock Details GBIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-500	Closed	-$1K	–	7384
2016 Q2	$1K	Sell	500 -84	-14%	-$149	﹤0.01%	7028
2016 Q1	$1K	Buy	584 +84	+17%	+$182	﹤0.01%	7395
2015 Q4	$2K	Sell	500 -45	-8%	-$144	﹤0.01%	7333
2015 Q3	$1K	Buy	545 +45	+9%	+$112	﹤0.01%	7305
2015 Q2	$1K	Sell	500 -297	-37%	-$1.85K	﹤0.01%	7433
2015 Q1	$6K	Buy	797 +297	+59%	+$2.15K	﹤0.01%	6685
2014 Q4	$4K	Sell	500 -500	-50%	-$3.48K	﹤0.01%	6763
2014 Q3	$7K	Buy	+1,000	New	+$10.2K	﹤0.01%	6448

Other funds holding GBIM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citigroup's GBIM Position: Q3 2016 in Review

Citigroup sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q3 2016, closing a stake of 500 shares — an estimated $1K sold.

Citigroup first reported a position in GBIM in Q3 2014 and held it in 8 quarters. The position peaked at $7K in Q3 2014. 1 fund tracked by Wall St. Rank holds GBIM as of Q3 2016.

Citigroup reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Citigroup sold 500 GLOBEIMMUNE INC COM STK (DE) shares in Q3 2016, an estimated $1K.
Citigroup first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q3 2014 and held it in 8 quarters.
Citigroup's GLOBEIMMUNE INC COM STK (DE) position peaked at $7K in Q3 2014.
1 fund tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q3 2016.

Based on Citigroup's 13F filing for Q3 2016, filed 10 Nov 2016.